# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-073470
Filing Date
2025-04-04
Accepted
2025-04-04 16:30:37
Documents
30
Period of Report
2025-05-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | d875367dpre14a.htm iXBRL | PRE 14A | 1271205
6 | GRAPHIC | g875367g00s76.jpg | GRAPHIC | 637191
7 | GRAPHIC | g875367g00s77.jpg | GRAPHIC | 562764
8 | GRAPHIC | g875367g00s78.jpg | GRAPHIC | 558303
9 | GRAPHIC | g875367g00s79.jpg | GRAPHIC | 540249
10 | GRAPHIC | g875367g00s85.jpg | GRAPHIC | 692598
11 | GRAPHIC | g875367g00s87.jpg | GRAPHIC | 692284
12 | GRAPHIC | g875367g00s89.jpg | GRAPHIC | 693159
13 | GRAPHIC | g875367g02a01.jpg | GRAPHIC | 35488
14 | GRAPHIC | g875367g02n02.jpg | GRAPHIC | 23869
15 | GRAPHIC | g875367g03g03.jpg | GRAPHIC | 22608
16 | GRAPHIC | g875367g60a01.jpg | GRAPHIC | 129542
17 | GRAPHIC | g875367page022.jpg | GRAPHIC | 184101
18 | GRAPHIC | g875367page023.jpg | GRAPHIC | 113196
| Complete submission text file | 0001193125-25-073470.txt |  | 14226399

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | xoma-20241231.xsd | EX-101.SCH | 3114
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | xoma-20241231_def.xml | EX-101.DEF | 1889
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | xoma-20241231_lab.xml | EX-101.LAB | 1719
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | xoma-20241231_pre.xml | EX-101.PRE | 694
32 | EXTRACTED XBRL INSTANCE DOCUMENT | d875367dpre14a_htm.xml | XML | 83037

Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39801 | Film No.: 25815183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)